Ohio State study identifies a likely key driver of colorectal cancer development and progression
- Posted: April 17, 2014
New targets are needed for agents that will more effectively treat colorectal cancer. This study, led by researchers at The Ohio State University Comprehensive Cancer Center, identifies a molecule that is probably a key driver of colorectal cancer.
Click here to read the full press release.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.